At the time of writing, Guardant Health Inc [GH] stock is trading at $109.93, down -2.14%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The GH shares have gain 9.27% over the last week, with a monthly amount glided 7.75%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Guardant Health Inc [NASDAQ: GH] stock has seen the most recent analyst activity on January 05, 2026, when Evercore ISI downgraded its rating to a In-line but kept the price target unchanged to $105 for it. On September 25, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $75 on the stock. Mizuho initiated its recommendation with an Outperform and recommended $55 as its price target on April 10, 2025. Barclays started tracking with an Overweight rating for this stock on January 23, 2025, and assigned it a price target of $60. In a note dated June 28, 2024, Guggenheim upgraded a Buy rating on this stock but restated the target price of $36.
For the past year, the stock price of Guardant Health Inc fluctuated between $34.55 and $112.44. Currently, Wall Street analysts expect the stock to reach $113.46 within the next 12 months. Guardant Health Inc [NASDAQ: GH] shares were valued at $109.93 at the most recent close of the market. An investor can expect a potential return of 3.21% based on the average GH price forecast.
Analyzing the GH fundamentals
According to Guardant Health Inc [NASDAQ:GH], the company’s sales were 902.57M for trailing twelve months, which represents an 38.50% jump. Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at -0.49%, Pretax Profit Margin comes in at -0.44%, and Net Profit Margin reading is -0.44%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is 1.52 and Total Capital is -0.43. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-3.74.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 107.72 points at the first support level, and at 105.50 for the second support level. However, for the 1st resistance point, the stock is sitting at 113.03, and for the 2nd resistance point, it is at 116.12.
Ratios To Look Out For
It is important to note that Guardant Health Inc [NASDAQ:GH] has a current ratio of 3.50. Further, the Quick Ratio stands at 3.12, while the Cash Ratio is 2.45. Considering the valuation of this stock, the price to sales ratio is 15.76.
Transactions by insiders
Recent insider trading involved Monroe Terilyn J., Officer, that happened on Jan 07 ’26 when 10031.0 shares were purchased. Director, Tariq Musa completed a deal on Dec 17 ’25 to sell 116.0 shares. Meanwhile, Co-Chief Executive Officer Eltoukhy Helmy sold 90565.0 shares on Dec 15 ’25.
